News

Tens of thousands of children and adults living with type 1 diabetes across England are set to receive an “artificial pancreas” in a world-first initiative being rolled out by the NHS.

The new device, rolled out from Tuesday, continually monitors a person’s blood glucose, then automatically adjusts the amount of insulin given to them through a pump.

Researchers say they have made a breakthrough in the treatment of type 1 diabetes which could replace the need for regular insulin injections. Research published by Baker Heart and Diabetes Institute scientists shows they have manipulated existing pancreatic stem cells to prompt them to produce insulin. The study from the Melbourne researchers builds on previous work by Monash University scientists, using two existing cancer drugs.

A new artificial intelligence model finds that x-ray images collected during routine medical care can provide warning signs for diabetes, even in patients who don’t meet the guidelines for elevated risk. The model could help physicians detect the disease earlier and prevent complications, says a multi-institutional team which published the findings in Nature Communications.

A team led by Van Andel Institute and Max Planck Institute of Immunobiology and Epigenetics scientists has identified two distinct subtypes of insulin-producing beta cells, or ß cells, each with crucial characteristics that may be leveraged to better understand and treat Type 1 and Type 2 diabetes.

It was in 2017 when 48-year-old Lynn Guzik suffered a massive heart attack out of the blue. An insulin-dependent diabetic for more than 20 years, Lynn struggled to control her diabetes, but she hadn’t had any heart issues before. The damage to her heart was significant, however, and in 2017, Lynn underwent a heart transplant in her then-hometown of Houston, Texas.

A newly published study from York University sheds light on the biological underpinnings in sex differences in obesity-related disease, with researchers observing “striking” differences in the cells that build blood vessels in the fatty tissue of male versus female mice.

Scientists from the Diabetes Research Institute at the University of Miami Miller School of Medicine have conclusively confirmed that progenitor